Professor Carlo Palmieri BSc(Hons), MB BS, PhD, FRCP(UK)
Carlo is a Professor of Translational Oncology at the University of Liverpool and Consultant medical oncologist at The Clatterbridge Cancer Centre NHS Foundation Trust. Carlo’s academic and clinical interest is in breast cancer, and his research interests are focused on hormone therapy for breast cancer and brain metastasis. He is actively involved in developing and initiating translational and clinical research trials and leads a number of studies including a national effort to collect CSF from patients with CNS disease secondary to breast cancer and a study investigating the feasibility of randomising patients with HER2 positive metastatic breast cancer to screening or nor. He co-leads CCP-UK CANCER a national NIHR URI funded project which is characterising COVID-19 in cancer patients. Regionally he co-chairs the Cheshire and Merseyside Cancer Alliance breast group. Nationalize co-chairs the National Cancer Research Institute (NCRI) Breast Working Group 2 (metastatic breast cancer), is a member of the NHS England Genomics Clinical Reference Group and has sat on the Independent Advisory Group which defined the patient groups deemed to be at very highest risk of an adverse COVID-19 outcome, to support the deployment of approved medication for treatment or prophlyaxis. He is a member of the Breast International Group (BIG) brain metastasis task force. He has co-edited ‘ABC of Cancer Care’ which aimed at non-specialists and students.
